Related Experiment Video
Updated: May 9, 2026
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Effects of a 1-year calcium-enriched permeate supplement on bone health in postmenopausal females: The RENEW
Inge Tetens1, Sadime B Kisi1, Alexandr Parlesak1
1Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Background:
Osteoporosis is a common age-related skeletal disorder, especially in postmenopausal females, underscoring the need for effective nutritional strategies to preserve bone health. Calcium-enriched permeate (CP) and inulin may enhance absorption and bone mineral density (BMD).
Objectives:
To assess the effects of daily supplementation of calcium-enriched permeate, with inulin (CP-Inu) or without inulin, and calcium carbonate (CC) on bone turnover markers and BMD in vitamin D-sufficient postmenopausal females.
Methods:
In this 12-mo randomized, double-blind, multi-center trial, postmenopausal females were allocated to receive daily either a maltodextrin as placebo (P), 800 mg calcium as CC, CP, or CP-Inu split into 2 doses. All received 20 μg vitamin D per day. Primary outcome was C-terminal telopeptides of type I collagen; secondary outcomes were procollagen type I N-terminal propeptide and BMD. Linear mixed-effects models were used to assess fixed and random effects. adjusted for multiple outcomes.
Results:
Of 417 participants (56.0 ± 4.2 y; BMI 25.5 ± 3.8), 316 (76%) completed the study with a mean 89% overall compliance. C-terminal telopeptides of type I collagen remained unchanged from baseline to 12 mo in the P group, whereas all intervention groups showed significant reductions compared with P (μg/L) [CC: β = -0.137; 95% confidence interval (CI): -0.193, -0.081, P = 2.59 × 10-6; CP: β: = -0.150; 95% CI: -0.208, -0.093, P = 1.62 × 10-6; CP-Inu β: = -0.149; 95% CI: -0.207, -0.090, P = 1.96 × 10-6]. Compared with P, procollagen type I N-terminal propeptide was significantly reduced in all intervention groups. By month 12, spine BMD (grams per square centimeter) was higher with CC: β = 0.0158, (0.0066, 0.0251), P = 0.0009; CP-Inu, β = 0.0142, (0.0046, 0.0238), P = 0.0040, and femoral neck BMD was higher with CP, β = 0.0116, (0.0042, 0.0190), P = 0.0022. No additional effects were observed in the CP-Inu group.
Conclusions:
Daily supplementation of 800 mg calcium in 2 doses from CP suppresses bone turnover markers and maintains BMD similarly to CC in vitamin D-sufficient postmenopausal females. Inulin provides no additional advantage. This trial was registered at clinicaltrials.gov as NCT04836637.
Related Concept Videos
01:40Bone Remodeling
01:20Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:31Osteoclasts in Bone Remodeling